Issue 12/2013
Content (10 Articles)
Acknowledgement to Referees
Acknowledgement
Leading Article
Novel Delivery Systems for Nicotine Replacement Therapy as an Aid to Smoking Cessation and for Harm Reduction: Rationale, and Evidence for Advantages over Existing Systems
Lion Shahab, Leonie S. Brose, Robert West
Review Article
Clinically Significant Drug Interactions with Atypical Antipsychotics
William Klugh Kennedy, Michael W. Jann, Eric C. Kutscher
Review Article
Animal Migraine Models for Drug Development: Status and Future Perspectives
Inger Jansen-Olesen, Peer Tfelt-Hansen, Jes Olesen
Review Article
Second Generation Antipsychotic-Induced Type 2 Diabetes: A Role for the Muscarinic M3 Receptor
Katrina Weston-Green, Xu-Feng Huang, Chao Deng
Open Access
Original Research Article
Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study
Ralf W. Dittmann, Esther Cardo, Peter Nagy, Colleen S. Anderson, Ralph Bloomfield, Beatriz Caballero, Nicholas Higgins, Paul Hodgkins, Andrew Lyne, Richard Civil, David Coghill
Original Research Article
Scopolamine Detoxification Technique for Heroin Dependence: A Randomized Trial
Sheng Liu, Longhui Li, Wenwen Shen, Xueyong Shen, Guodong Yang, Wenhua Zhou
Adis Drug Evaluation
Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis
Karly P. Garnock-Jones
Adis Drug Evaluation
Lacosamide: A Review of Its Use as Adjunctive Therapy in the Management of Partial-Onset Seizures
Sheridan M. Hoy
Erratum
Erratum to: Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy
Warrington W. Q. Hsu, C. W. Sing, Ying He, Alan J. Worsley, Ian C. K. Wong, Esther W. Chan